Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 21, 2011; 17(47): 5197-5202
Published online Dec 21, 2011. doi: 10.3748/wjg.v17.i47.5197
Published online Dec 21, 2011. doi: 10.3748/wjg.v17.i47.5197
Variable | Cases (n = 1156) | Controls (n = 4624) | Odds ratio (95% CI) |
Age, yr (mean ± SD) | 68.34 ± 10.40 | 69.29 ± 10.40 | - |
Female (%) | 447 (38.67) | 1788 (38.67) | - |
No. of hospitalizations | 0.29 ± 0.93 | 0.26 ± 0.74 | P = 0.23 |
Diabetes (%) | 422 (36.51) | 1560 (33.74) | 1.13 (0.99-1.29) |
Cholecystectomy (%) | 21 (1.82) | 105 (2.27) | 0.80 (0.50-1.28) |
Liver disease (%) | 422 (36.51) | 1861 (40.25) | 0.85 (0.75-0.98) |
Colorectal polyps (%) | 56 (4.84) | 76 (1.64) | 3.05 (2.14-4.33) |
Inflammatory bowel disease (%) | 82 (7.09) | 315 (6.81) | 1.04 (0.81-1.34) |
Colonoscopy (%) | 153 (13.24) | 42 (0.91) | 16.64 (11.75-23.57) |
FOBT (%) | 152 (13.15) | 216 (4.67) | 3.09 (2.48-3.84) |
NSAID (%) | 636 (55.02) | 2767 (59.84) | 0.82 (0.72-0.93) |
Use of other lipid-lowering drugs (%) | 31 (2.68) | 180 (3.89) | 0.68 (0.46-1.00) |
- Citation: Cheng MH, Chiu HF, Ho SC, Tsai SS, Wu TN, Yang CY. Statin use and the risk of colorectal cancer: A population-based case-control study. World J Gastroenterol 2011; 17(47): 5197-5202
- URL: https://www.wjgnet.com/1007-9327/full/v17/i47/5197.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i47.5197